Overall rank by patents
#2,133
Across all tracked assignees
USPTO PatentsView assignee record - 185 granted patents across 94 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C22C (ALLOYS).
The verdict
Proterial holds 185 US patents across 94 technology areas, rank #2,133 of 50,000 tracked assignees.
Proterial, Ltd. has been granted 185 US utility patents between 2023 and 2025, placing Proterial, Ltd. at rank #2,133 across all assignees tracked by PlainPatent. This portfolio spans 94 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.7 claims per patent with primary concentration in C22C (ALLOYS). As a Foreign Corporation, Proterial, Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Proterial sits between Fujitsu Semiconductor Limited (185 patents, rank #2,129) and Asics Corporation (184 patents, rank #2,137) - the closest US assignees by grant volume. The composite Innovation Score of 68.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 185 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Proterial, Ltd.'s 9.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 94 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Proterial, Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FUJITSU SEMICONDUCTOR LIMITED
185 patents
National Taiwan University of Science and Technology
185 patents
OSSUR ICELAND EHF
185 patents
PETRÓLEO BRASILEIRO S.A.—PETROBRAS
185 patents
PerkinElmer Health Sciences, Inc.
185 patents
RAYTHEON BBN TECHNOLOGIES CORP.
185 patents
ZEDEL
185 patents
PROTERIAL, LTD.
185 patents
ASICS CORPORATION
184 patents
What this shows Proterial holds 185 patents at rank #2,133, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,133 in granted patent volume.
Other assignees with the most granted patents in Proterial's primary technology class.
Proterial's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
69 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 65 | 35.1% |
| 2024 | 74 | 40.0% |
| 2025 | 46 | 24.9% |
Top 15 of 94 technology areas
Overall rank by patents
#2,133
Across all tracked assignees
68.9 out of 100
How to use this portfolio
Proterial's 185 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.